Naoe Jimbo

Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report

Kazuhiro Minami, Naoe Jimbo, Yugo Tanaka et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2019 · 34 citations

Tumoral Pathology, Malignant Disease, Malignant Mesothelioma +7

MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas

Naoe Jimbo, Masato Komatsu, Tomoo Itoh et al. · Cardiovascular Pathology · 2019 · 31 citations

Oncologic Imaging, Medicine, Surgical Pathology +6

Gene Expression and Methylation Analysis in Melanomas and Melanocytes From the Same Patient: Loss of NPM2 Expression Is a Potential Immunohistochemical Marker for Melanoma

Susumu Fujiwara, Hiroshi Nagai, Haruki Jimbo et al. · Frontiers in Oncology · 2019 · 22 citations · Full text

Hepatic angiomyolipomas may overexpress TFE3, but have no relevant genetic alterations

Naoe Jimbo, Takashi Nishigami, Masayuki Noguchi et al. · Human Pathology · 2016 · 18 citations

Hepatic Angiomyolipomas, Hepatology, Genetics +3

High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma

Ryota Dokuni, Tatsuya Nagano, Naoe Jimbo et al. · Respiratory Research · 2020 · 18 citations · Full text